Avalo Therapeutics (AVTX) Q4 2022 Earnings

29MarConfirmed
May 22
Aug 22
Nov 22
Q4 2022
-2.4
-1.49
-0.57
0.34

Details

Expected EPS
-0.73
Actual EPS
-1.04
Surprise EPS
-0.31
Surprise Percent
+42.47%

Description

Avalo Therapeutics (AVTX) has reported earnings of -1.04 per share for Q4 2022.

0 Comments

Share your thoughts